Sanofi's Dupixent is still breaking new ground in inflammatory illnesses five years after receiving FDA approval for the first time...
Read moreThe pharma version of Fast and Furious has a new superhero. How else to characterise AbbVie's Rinvoq's breakthrough effectiveness? The...
Read moreCatalent, the high-flying CDMO, is buying a cell therapy unit on the East Coast, only days after spending $350 million...
Read morePfizer's recall saga has now reached the United States, after elevated concentrations of potential carcinogens forced the company to pull...
Read moreThe FDA's Office of Prescription Medicine Promotion (OPDP) intends to know how patients and doctors consider the risks and benefits of...
Read moreInsulet added to its portfolio of life-changing diabetes management technologies when its Omnipod 5 received FDA clearance in January. Omnipod...
Read moreAs worldwide demand dwindles, around 200 million doses of COVID-19 vaccine are rusting away in the world's largest vaccine manufacturer's...
Read moreSanofi's "factory of the future" in Singapore could be operational by the middle of the decade. One of two so-called...
Read moreTo become self-reliant, Union Commerce and Industry Minister of India, Piyush Goyal advised the domestic pharmaceutical sector to develop its generic medicine...
Read moreKing's College London, a public research university, is using messenger RNA (mRNA) technology to battle the physiological effects of cardiac...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.